What Are the Main Themes Concerned by the Second-line SMUR 67, Known as Reinforcements, in the Bas-Rhin Sector

State of Play at the SAMU 67: What Are the Themes Mainly Concerned by the Second Intention SMUR, Called Reinforcements, on the Sector of the Bas-Rhin? Are There Modifiable Factors That Could Allow us to Anticipate Them Better

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06182514

Acronym

RenforSMUR

Enrollment

1200

Registered

2023-12-27

Start date

2022-07-01

Completion date

2024-06-30

Last updated

2023-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reasons for Emergency Calls

Keywords

emergency calls, SAMU67, SMUR

Brief summary

In this study the investigators wish to evaluate the possibility of anticipating the requests for SMUR reinforcement within the SAMU67. The studied population concerns each patient having benefited from an SMUR at the time of his pre-hospital care. The investigators expect from this study an improvement of the assumption of responsibility of the patients in the future with optimization of the delay of sending of an SMUR when this one is necessary.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Months to No maximum

Inclusion criteria

* Adult patients having benefited from a pre-hospital SMUR over the period from 01/01/2020 to 14/07/2020. * No opposition from the patient or his parental authority to the re-use of his medical data for scientific research.

Exclusion criteria

\- Presence of opposition from the patient or his parental authority to the re-use of his medical data for scientific research purposes.

Design outcomes

Primary

Measure	Time frame
Retrospective description of the main reasons and themes of patient calls leading to the Emergency Medical Service being sent for reinforcement	Through study completion, an average of 12 months

Countries

France

Contacts

Primary ContactAnne WACH-HOFFMANN, MD

anne.hoffmann@chru-strasbourg.fr33 3 88 12 81 79

Outcome results